RELCHEMQ
Reliance Chemotex Industries Limited
Reliance Chemotex Industries Limited (RELCHEMQ) financial statements and selected valuation metrics through 30 June 2026.
Consumer Discretionary›Textiles›Textiles & Apparels›Other Textile Products
reliancechemotex.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Reliance Chemotex makes textile products at its own manufacturing unit in Udaipur, Rajasthan, and sells them from there and from its Mumbai corporate office.
Company snapshot
79thBy market cap
Ranked among 100 companies in Other Textile Products.
What we see
- ✗Net margin is very thin at 1.5% — little room for error if costs rise.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 89 Cr | 85 Cr | 102 Cr | 93 Cr | 92 Cr | 92 Cr | 82 Cr | 92 Cr | 100 Cr | 82 Cr | 88 Cr | 99 Cr |
| Operating expenses (approx.) | 82 Cr | 78 Cr | 95 Cr | 87 Cr | 86 Cr | 83 Cr | 71 Cr | 82 Cr | 89 Cr | 71 Cr | 79 Cr | 88 Cr |
| EBITDA | 7 Cr | 7 Cr | 8 Cr | 6 Cr | 6 Cr | 9 Cr | 11 Cr | 11 Cr | 10 Cr | 11 Cr | 9 Cr | 11 Cr |
| OPM % | 7.8% | 8.7% | 7.5% | 6.3% | 6.7% | 9.7% | 13.8% | 11.6% | 10.3% | 13.1% | 10.2% | 10.9% |
| Other income | 0.81 Cr | 0.95 Cr | 1 Cr | 4 Cr | 4 Cr | 0.56 Cr | 2 Cr | 0.39 Cr | 0.36 Cr | 0.40 Cr | 3 Cr | 0.90 Cr |
| Interest | 5 Cr | 5 Cr | 5 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 7 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr |
| Profit before tax | 0.42 Cr | 0.91 Cr | 1 Cr | 0.17 Cr | 0.34 Cr | 0.12 Cr | 3 Cr | 0.96 Cr | 1 Cr | 1 Cr | 2 Cr | 1 Cr |
| Tax % | -9.7% | 93.2% | 69.2% | -240.6% | -321.4% | -64.5% | 39.2% | -11.3% | -55.1% | 26.1% | -0.4% | -5.1% |
| Net profit | 0.46 Cr | 0.06 Cr | 0.46 Cr | 0.59 Cr | 1 Cr | 0.19 Cr | 2 Cr | 1 Cr | 2 Cr | 0.80 Cr | 2 Cr | 1 Cr |
| EPS (₹) | ₹0.61 | ₹0.08 | ₹0.61 | ₹0.78 | ₹1.89 | ₹0.26 | ₹2.44 | ₹1.41 | ₹2.19 | ₹1.06 | ₹2.31 | ₹1.81 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 295 Cr | 285 Cr | 323 Cr | 300 Cr | 256 Cr | 362 Cr | 365 Cr | 367 Cr | 359 Cr | 362 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 273 Cr | 266 Cr | 298 Cr | 271 Cr | 233 Cr | 320 Cr | 331 Cr | 336 Cr | 326 Cr | 321 Cr | Sign in free for the trailing twelve months |
| EBITDA | 22 Cr | 19 Cr | 26 Cr | 28 Cr | 23 Cr | 41 Cr | 34 Cr | 31 Cr | 32 Cr | 41 Cr | Sign in free for the trailing twelve months |
| OPM % | 7.5% | 6.7% | 7.9% | 9.5% | 9.0% | 11.5% | 9.4% | 8.5% | 9.0% | 11.2% | Sign in free for the trailing twelve months |
| Other income | 4 Cr | 1 Cr | 2 Cr | 1 Cr | 4 Cr | 7 Cr | 6 Cr | 4 Cr | 10 Cr | 4 Cr | Sign in free for the trailing twelve months |
| Interest | 14 Cr | 12 Cr | 13 Cr | 11 Cr | 10 Cr | 12 Cr | 14 Cr | 20 Cr | 24 Cr | 25 Cr | Sign in free for the trailing twelve months |
| Depreciation | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 8 Cr | 9 Cr | 10 Cr | 10 Cr | 15 Cr | 15 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 5 Cr | 0.81 Cr | 8 Cr | 11 Cr | 10 Cr | 27 Cr | 17 Cr | 6 Cr | 4 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Tax % | -35.3% | -218.8% | 49.1% | 13.4% | 33.1% | 33.7% | 25.7% | 43.0% | -10.6% | -8.7% | Sign in free for the trailing twelve months |
| Net profit | 6 Cr | 3 Cr | 4 Cr | 9 Cr | 7 Cr | 18 Cr | 12 Cr | 3 Cr | 4 Cr | 5 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹16.29 | ₹6.53 | ₹10.28 | ₹14.68 | ₹9.19 | ₹24.04 | ₹16.46 | ₹4.26 | ₹5.36 | ₹6.97 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 10.2% | 8.3% | 15.2% | 58.8% | 18.6% | 7.2% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 4 Cr | 4 Cr | 4 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr |
| Reserves | 64 Cr | 66 Cr | 63 Cr | 91 Cr | 97 Cr | 114 Cr | 124 Cr | 126 Cr | 130 Cr | 135 Cr |
| Borrowings | 81 Cr | 83 Cr | 74 Cr | 50 Cr | 87 Cr | 117 Cr | 196 Cr | 279 Cr | 261 Cr | 267 Cr |
| Other liabilities | 78 Cr | 74 Cr | 77 Cr | 79 Cr | 71 Cr | 95 Cr | 69 Cr | 69 Cr | 76 Cr | 102 Cr |
| Total liabilities | 227 Cr | 228 Cr | 218 Cr | 227 Cr | 263 Cr | 333 Cr | 397 Cr | 481 Cr | 474 Cr | 512 Cr |
| Fixed assets (net) | 151 Cr | 145 Cr | 137 Cr | 140 Cr | 146 Cr | 179 Cr | 193 Cr | 315 Cr | 310 Cr | 296 Cr |
| CWIP | — | — | 0 Cr | 0 Cr | 1 Cr | 10 Cr | 39 Cr | 0.80 Cr | 0 Cr | 0 Cr |
| Investments | — | — | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Inventories | 38 Cr | 41 Cr | 38 Cr | 35 Cr | 47 Cr | 44 Cr | 45 Cr | 54 Cr | 69 Cr | 99 Cr |
| Trade receivables | 18 Cr | 17 Cr | 18 Cr | 13 Cr | 11 Cr | 5 Cr | 7 Cr | 6 Cr | 18 Cr | 10 Cr |
| Cash & bank | 0.78 Cr | 0.23 Cr | 0.13 Cr | 0.77 Cr | 0.32 Cr | 0.07 Cr | 4 Cr | 0.27 Cr | 0.58 Cr | 0.41 Cr |
| Other assets | 19 Cr | 24 Cr | 23 Cr | 36 Cr | 55 Cr | 92 Cr | 106 Cr | 103 Cr | 75 Cr | 104 Cr |
| Total assets | 227 Cr | 228 Cr | 218 Cr | 227 Cr | 263 Cr | 333 Cr | 397 Cr | 481 Cr | 474 Cr | 512 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 32 Cr | 11 Cr | 26 Cr | 22 Cr | 27 Cr | 58 Cr | -0.04 Cr | 18 Cr | 11 Cr | 22 Cr |
| Cash from investing | -2 Cr | -0.11 Cr | -0.24 Cr | -8 Cr | -43 Cr | -74 Cr | -51 Cr | -82 Cr | 33 Cr | -2 Cr |
| Cash from financing | -30 Cr | -11 Cr | -26 Cr | -13 Cr | 15 Cr | 15 Cr | 55 Cr | 60 Cr | -43 Cr | -20 Cr |
| Net cash flow | -0.18 Cr | -0.55 Cr | -0.10 Cr | 0.64 Cr | -0.45 Cr | -0.25 Cr | 4 Cr | -4 Cr | 0.31 Cr | -0.17 Cr |
| Free cash flow (OCF − Capex) | 28 Cr | 10 Cr | 25 Cr | 15 Cr | 11 Cr | 10 Cr | -54 Cr | -75 Cr | 2 Cr | 21 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 12.5% | 8.6% | 15.0% | 14.9% | 10.4% | 16.6% | 9.3% | 6.1% | 7.0% | 7.3% |
| ROE % | 9.5% | 3.7% | 6.1% | 9.5% | 6.6% | 14.9% | 9.4% | 2.4% | 2.9% | 3.7% |
| Debtor days | 23 | 22 | 20 | 16 | 15 | 5 | 7 | 6 | 18 | 10 |
| Inventory days | 85 | 94 | 74 | 84 | 136 | 88 | 89 | 100 | 134 | 193 |
| Days payable | 78 | 81 | 70 | 92 | 57 | 60 | 28 | 31 | 54 | 47 |
| Cash conversion cycle | 29 | 35 | 24 | 8 | 94 | 34 | 68 | 75 | 99 | 155 |
| OCF / EBITDA % | 144.4% | 56.0% | 101.1% | 76.0% | 117.5% | 140.2% | -0.1% | 57.8% | 33.5% | 53.2% |
| OCF / EBITDA % (3 years) | — | — | 102.5% | 79.5% | 96.8% | 114.9% | 86.3% | 71.2% | 29.4% | 48.5% |
| Debt / equity | 1.20 | 1.18 | 1.10 | 0.51 | 0.84 | 0.96 | 1.49 | 2.09 | 1.90 | 1.87 |
| Current ratio | 0.88 | 0.84 | 0.94 | 0.94 | 1.03 | 0.96 | 0.88 | 0.95 | 0.91 | 1.07 |
| Net debt / EBITDA | 3.65 | 4.32 | 2.89 | 1.73 | 3.76 | 2.82 | 5.61 | 8.97 | 8.08 | 6.55 |